ENTRY       D01337                      Drug
NAME        Epoprostenol sodium (JAN/USAN);
            Flolan (TN);
            Veletri (TN)
PRODUCT     EPOPROSTENOL SODIUM (GlaxoSmithKline LLC)
            VELETRI (Actelion Pharmaceuticals US)
  GENERIC   EPOPROSTENOL (Sun Pharmaceutical Industries)
FORMULA     C20H31O5. Na
EXACT_MASS  374.2069
MOL_WEIGHT  374.4469
CLASS       Blood modifier agent
             DG01950  Antithrombotic agent
              DG01712  Antiplatelet agent
            Hormonal agent
             DG01961  Prostaglandin derivative
              DG01810  Prostacycline derivative
REMARK      Therapeutic category: 2190
            ATC code: B01AC09
            Chemical structure group: DG00157
            Product (DG00157): D01337<JP/US>
EFFICACY    Antihypertensive, Platelet aggregation inhibitor, Prostaglandin I2 receptor agonist
  DISEASE   Pulmonary arterial hypertension [DS:H01621]
COMMENT     Prostacycline derivative
TARGET      PTGIR [HSA:5739] [KO:K04263]
  PATHWAY   hsa04080(5739)  Neuroactive ligand-receptor interaction
            hsa04270(5739)  Vascular smooth muscle contraction
            hsa04611(5739)  Platelet activation
INTERACTION  
STR_MAP     map07034  Eicosanoids
            map07049  Antithrombosis agents
            map07228  Eicosanoid receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             B BLOOD AND BLOOD FORMING ORGANS
              B01 ANTITHROMBOTIC AGENTS
               B01A ANTITHROMBOTIC AGENTS
                B01AC Platelet aggregation inhibitors excl. heparin
                 B01AC09 Epoprostenol
                  D01337  Epoprostenol sodium (JAN/USAN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Respiratory Tract/Pulmonary Agents
              Pulmonary Antihypertensives
               Prostacyclin Vasodilators
                Epoprostenol
                 D01337  Epoprostenol sodium (JAN/USAN)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               219  Miscellaneous
                2190  Miscellaneous
                 D01337  Epoprostenol sodium (JAN/USAN)
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                DG00157  Epoprostenol
                 D01337  Epoprostenol sodium
             Hormonal agent
              DG01961  Prostaglandin derivative
               DG01810  Prostacycline derivative
                DG00157  Epoprostenol
                 D01337  Epoprostenol sodium
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Prostacyclin
                PTGIR
                 D01337  Epoprostenol sodium (JAN/USAN) &lt;JP/US&gt;
            Drug groups [BR:br08330]
             Blood modifier agent
              DG01950  Antithrombotic agent
               DG01712  Antiplatelet agent
                DG00157  Epoprostenol
             Hormonal agent
              DG01961  Prostaglandin derivative
               DG01810  Prostacycline derivative
                DG00157  Epoprostenol
DBLINKS     CAS: 61849-14-7
            PubChem: 7848400
            ChEBI: 31548
            LigandBox: D01337
            NIKKAJI: J18.157I
ATOM        26
            1   Z   Na   26.1044  -10.2395 #+
            2   C1y C    25.1300  -19.0400
            3   C1y C    23.8000  -18.6200
            4   C1y C    25.1300  -20.4400
            5   C1x C    25.8300  -17.7800
            6   O2x O    23.8000  -17.1500
            7   C1x C    23.0300  -19.7400
            8   C1y C    23.8700  -20.8600
            9   C2b C    26.3200  -21.1400
            10  C2y C    25.1300  -16.5200
            11  O1a O    23.3800  -22.1900
            12  C2b C    27.5100  -20.4400
            13  C2b C    26.3200  -15.8200
            14  C1c C    28.7000  -21.1400
            15  C1b C    29.9600  -20.4400
            16  O1a O    28.7000  -22.4700
            17  C1b C    31.1500  -21.1400
            18  C1b C    32.3400  -20.4400
            19  C1b C    33.5300  -21.1400
            20  C1a C    34.7200  -20.4400
            21  C1b C    26.3900  -14.4200
            22  C1b C    27.5800  -13.7200
            23  C1b C    27.5800  -12.3200
            24  C6a C    28.7700  -11.6200
            25  O6a O    30.0300  -12.3200
            26  O6a O    28.7700  -10.2200 #-
BOND        26
            1     2   3 1
            2     2   4 1
            3     2   5 1 #Down
            4     3   6 1 #Down
            5     3   7 1
            6     4   8 1
            7     4   9 1 #Up
            8     5  10 1
            9     8  11 1 #Down
            10    9  12 2
            11   10  13 2
            12   12  14 1
            13   14  15 1
            14   14  16 1 #Down
            15   15  17 1
            16   17  18 1
            17   18  19 1
            18   19  20 1
            19    6  10 1
            20    7   8 1
            21   13  21 1
            22   21  22 1
            23   22  23 1
            24   23  24 1
            25   24  25 2
            26   24  26 1
///
